SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001787306-24-000061
Filing Date
2024-04-26
Accepted
2024-04-26 16:31:11
Documents
21
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A arqt-20240426.htm   iXBRL DEF 14A 616825
6 arqt-20240426_g1.jpg GRAPHIC 30366
7 arqt-20240426_g2.jpg GRAPHIC 38946
8 arqt-20240426_g3.jpg GRAPHIC 57652
9 arqt-20240426_g4.jpg GRAPHIC 313620
10 arqt-20240426_g5.jpg GRAPHIC 286302
11 arqt-20240426_g6.jpg GRAPHIC 452302
12 arqt-20240426_g7.jpg GRAPHIC 181988
  Complete submission text file 0001787306-24-000061.txt   4152039

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240426.xsd EX-101.SCH 3279
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20240426_def.xml EX-101.DEF 4203
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240426_lab.xml EX-101.LAB 5439
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240426_pre.xml EX-101.PRE 3208
24 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240426_htm.xml XML 64299
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39186 | Film No.: 24884393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)